JP2007529196A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007529196A5 JP2007529196A5 JP2006526599A JP2006526599A JP2007529196A5 JP 2007529196 A5 JP2007529196 A5 JP 2007529196A5 JP 2006526599 A JP2006526599 A JP 2006526599A JP 2006526599 A JP2006526599 A JP 2006526599A JP 2007529196 A5 JP2007529196 A5 JP 2007529196A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- binding molecule
- ser
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/666,332 | 2003-09-18 | ||
| US10/666,332 US20050069538A1 (en) | 2003-09-18 | 2003-09-18 | Therapeutic binding molecules |
| GB0414309.5 | 2004-06-25 | ||
| GB0414309A GB0414309D0 (en) | 2004-06-25 | 2004-06-25 | Organic compounds |
| PCT/EP2004/010471 WO2005026210A2 (en) | 2003-09-18 | 2004-09-17 | Therapeutic binding molecules |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007529196A JP2007529196A (ja) | 2007-10-25 |
| JP2007529196A5 true JP2007529196A5 (enExample) | 2008-04-17 |
| JP4762142B2 JP4762142B2 (ja) | 2011-08-31 |
Family
ID=34315457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006526599A Expired - Fee Related JP4762142B2 (ja) | 2003-09-18 | 2004-09-17 | 治療用結合分子 |
Country Status (28)
| Country | Link |
|---|---|
| EP (1) | EP1664122B1 (enExample) |
| JP (1) | JP4762142B2 (enExample) |
| KR (1) | KR20060079232A (enExample) |
| AR (2) | AR045765A1 (enExample) |
| AT (1) | ATE461219T1 (enExample) |
| AU (1) | AU2004272289B2 (enExample) |
| BR (1) | BRPI0414515A (enExample) |
| CA (1) | CA2537217A1 (enExample) |
| CY (1) | CY1110033T1 (enExample) |
| DE (1) | DE602004026081D1 (enExample) |
| DK (1) | DK1664122T3 (enExample) |
| EC (1) | ECSP066432A (enExample) |
| ES (1) | ES2341341T3 (enExample) |
| HR (1) | HRP20100334T1 (enExample) |
| IL (1) | IL173820A0 (enExample) |
| IS (1) | IS8397A (enExample) |
| MA (1) | MA28041A1 (enExample) |
| MY (1) | MY143963A (enExample) |
| NO (1) | NO20061681L (enExample) |
| NZ (1) | NZ545605A (enExample) |
| PE (1) | PE20060019A1 (enExample) |
| PL (1) | PL1664122T3 (enExample) |
| PT (1) | PT1664122E (enExample) |
| RU (1) | RU2386639C2 (enExample) |
| SI (1) | SI1664122T1 (enExample) |
| TN (1) | TNSN06087A1 (enExample) |
| TW (1) | TW200521231A (enExample) |
| WO (1) | WO2005026210A2 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2502631A1 (en) | 2011-03-22 | 2012-09-26 | Medizinische Hochschule Hannover | Immune suppressor and its use |
| GB201409558D0 (en) | 2014-05-29 | 2014-07-16 | Ucb Biopharma Sprl | Method |
| GB201412659D0 (en) | 2014-07-16 | 2014-08-27 | Ucb Biopharma Sprl | Molecules |
| GB201412658D0 (en) | 2014-07-16 | 2014-08-27 | Ucb Biopharma Sprl | Molecules |
| CN105886609B (zh) * | 2015-02-17 | 2020-02-21 | 陈沛隆 | 药物不良反应风险评估方法及其装置 |
| EP3280720A4 (en) | 2015-04-06 | 2018-12-05 | President and Fellows of Harvard College | Compositions and methods for non-myeloablative conditioning |
| GB201601077D0 (en) | 2016-01-20 | 2016-03-02 | Ucb Biopharma Sprl | Antibody molecule |
| GB201601075D0 (en) | 2016-01-20 | 2016-03-02 | Ucb Biopharma Sprl | Antibodies molecules |
| GB201601073D0 (en) * | 2016-01-20 | 2016-03-02 | Ucb Biopharma Sprl | Antibodies |
| GB201521389D0 (en) | 2015-12-03 | 2016-01-20 | Ucb Biopharma Sprl | Method |
| GB201521393D0 (en) | 2015-12-03 | 2016-01-20 | Ucb Biopharma Sprl | Antibodies |
| GB201521391D0 (en) | 2015-12-03 | 2016-01-20 | Ucb Biopharma Sprl | Antibodies |
| GB201521382D0 (en) | 2015-12-03 | 2016-01-20 | Ucb Biopharma Sprl | Antibodies |
| GB201521383D0 (en) | 2015-12-03 | 2016-01-20 | Ucb Biopharma Sprl And Ucb Celltech | Method |
| AU2017204139B2 (en) * | 2016-06-17 | 2018-08-09 | Regeneron Pharmaceuticals, Inc. | Compositions and methods for the depletion of cells |
| WO2018222901A1 (en) | 2017-05-31 | 2018-12-06 | Elstar Therapeutics, Inc. | Multispecific molecules that bind to myeloproliferative leukemia (mpl) protein and uses thereof |
| SG11202004294XA (en) | 2017-11-29 | 2020-06-29 | Magenta Therapeutics Inc | Compositions and methods for the depletion of cd5+ cells |
| CN116724060A (zh) * | 2020-07-24 | 2023-09-08 | 小利兰·斯坦福大学董事会 | 调节SIRPα介导的信号传导的组合物和方法 |
| JP2023547795A (ja) | 2020-10-15 | 2023-11-14 | ユーシービー バイオファルマ エスアールエル | Ｃｄ４５を多量体化する結合分子 |
| WO2022140388A1 (en) | 2020-12-21 | 2022-06-30 | Allogene Therapeutics, Inc. | Protease-activating cd45-gate car |
| EP4433512A4 (en) | 2021-11-19 | 2025-12-31 | Univ Pennsylvania | Genetically modified pan-leukocyte-specific CD45 antigen to facilitate T-lymphocyte therapy |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG67924A1 (en) * | 1991-07-25 | 1999-10-19 | Idec Pharma Corp | Recombinant antibodies for human therapy |
| US6106834A (en) * | 1993-06-02 | 2000-08-22 | Research Corporation Technologies, Inc. | Use of anti-CD45 leukocyte antigen antibodies for immunomodulation |
| GB0103389D0 (en) * | 2001-02-12 | 2001-03-28 | Novartis Ag | Organic compounds |
-
2004
- 2004-09-17 ES ES04765363T patent/ES2341341T3/es not_active Expired - Lifetime
- 2004-09-17 PT PT04765363T patent/PT1664122E/pt unknown
- 2004-09-17 DK DK04765363.9T patent/DK1664122T3/da active
- 2004-09-17 TW TW093128255A patent/TW200521231A/zh unknown
- 2004-09-17 AR ARP040103362A patent/AR045765A1/es active IP Right Grant
- 2004-09-17 NZ NZ545605A patent/NZ545605A/en not_active IP Right Cessation
- 2004-09-17 DE DE602004026081T patent/DE602004026081D1/de not_active Expired - Lifetime
- 2004-09-17 CA CA002537217A patent/CA2537217A1/en not_active Abandoned
- 2004-09-17 HR HR20100334T patent/HRP20100334T1/hr unknown
- 2004-09-17 MY MYPI20043795A patent/MY143963A/en unknown
- 2004-09-17 PE PE2004000909A patent/PE20060019A1/es not_active Application Discontinuation
- 2004-09-17 PL PL04765363T patent/PL1664122T3/pl unknown
- 2004-09-17 BR BRPI0414515-1A patent/BRPI0414515A/pt not_active Application Discontinuation
- 2004-09-17 JP JP2006526599A patent/JP4762142B2/ja not_active Expired - Fee Related
- 2004-09-17 RU RU2006112598/13A patent/RU2386639C2/ru not_active IP Right Cessation
- 2004-09-17 AU AU2004272289A patent/AU2004272289B2/en not_active Ceased
- 2004-09-17 WO PCT/EP2004/010471 patent/WO2005026210A2/en not_active Ceased
- 2004-09-17 KR KR1020067005352A patent/KR20060079232A/ko not_active Ceased
- 2004-09-17 SI SI200431411T patent/SI1664122T1/sl unknown
- 2004-09-17 AT AT04765363T patent/ATE461219T1/de active
- 2004-09-17 EP EP04765363A patent/EP1664122B1/en not_active Expired - Lifetime
-
2006
- 2006-02-20 IL IL173820A patent/IL173820A0/en not_active IP Right Cessation
- 2006-03-14 MA MA28875A patent/MA28041A1/fr unknown
- 2006-03-17 TN TNP2006000087A patent/TNSN06087A1/en unknown
- 2006-03-17 EC EC2006006432A patent/ECSP066432A/es unknown
- 2006-04-03 IS IS8397A patent/IS8397A/is unknown
- 2006-04-12 NO NO20061681A patent/NO20061681L/no not_active Application Discontinuation
-
2010
- 2010-05-14 CY CY20101100424T patent/CY1110033T1/el unknown
- 2010-12-14 AR ARP100104624A patent/AR079458A2/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007529196A5 (enExample) | ||
| AU2009245354C1 (en) | Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof | |
| ES2744526T3 (es) | Anticuerpos anti-MCAM y métodos de uso asociados | |
| TWI673287B (zh) | 抗b7-h3抗體、其抗原結合片段及其醫藥用途 | |
| JP2020504171A (ja) | 抗ＰＤ−１抗体との組み合わせのための抗Ｔｉｍ−３抗体 | |
| JP7257971B2 (ja) | 抗ｃｄ４０抗体、その抗原結合フラグメント、およびその医学的使用 | |
| EP2928919A2 (en) | Blood-brain barrier (bbb) penetrating dual specific binding proteins | |
| CN111138540A (zh) | 治疗自身免疫疾病的结合fcrn的抗体 | |
| WO2015191934A2 (en) | Blood-brain barrier (bbb) penetrating dual specific binding proteins for treating brain and neurological diseases | |
| RU2003126168A (ru) | Терапевтические связывающие молекулы | |
| RU2006112598A (ru) | Связывающие молекулы, обладающие терапевтической активностью | |
| CN105745225A (zh) | Nav1.7抗体和使用所述抗体的方法 | |
| TW202134286A (zh) | 抗ｇｐｃ３抗體、其抗原結合片段及其醫藥用途 | |
| CN116249717A (zh) | 识别分拣蛋白的抗体 | |
| JP7366353B2 (ja) | 抗インドキシル硫酸の単離されたモノクローナル抗体及び／又はその抗原結合断片の組成物及びその用途 | |
| WO2025014712A2 (en) | Antibodies against cd14 and uses thereof | |
| US20200131263A1 (en) | Anti-gitr antibody, antigen-binding fragment thereof, and pharmaceutical use thereof | |
| CN115298216A (zh) | 抗体或其抗原结合片段、其制备方法及医药用途 | |
| CA3242070A1 (en) | Antibodies recognizing sortilin | |
| JP2024523514A (ja) | 抗ｃｄ４０抗体、その抗原結合断片及び医薬用途 | |
| CN114761042A (zh) | Il-38特异性抗体 | |
| WO2019109974A1 (zh) | 抗pd-l1抗体及其抗原结合片段 | |
| RU2795411C2 (ru) | Моноклональные антитела к интерлейкину-31 для ветеринарного применения | |
| JP2026050358A (ja) | 治療用抗ｃｄ４０リガンド抗体 | |
| KR20260016944A (ko) | 항-클라우딘18.2 항체 및 이의 제조 및 사용 방법 |